Has John Keene received payments from drug or device companies?

Yes. Drug and device makers reported $2,690 in general payments to John Keene across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Keene did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Keene come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Keene

Oral and Maxillofacial Surgery · Westbury, NYNPI 1588678502

Payments from drug & device makers

$2,690in general payments, 2019–2025

Across 31 payments — averaging $86.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Henry Schein, Inc.$1K
Nobel Biocare USA$591
Biohorizons Implant Systems Inc.$169
Keystone Dental Inc.$155
Straumann USA LLC$150
Dentsply Sirona Inc$147
plus $77 from 2 others

What the payments were for

Speaking & faculty fees$1,62961%
Food & beverage$80730%
Education$1004%
Entertainment$1556%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Henry Schein, Inc.	4	$1,400
Nobel Biocare USA	9	$591
Biohorizons Implant Systems Inc.	6	$169
Keystone Dental Inc.	3	$155
Straumann USA LLC	4	$150
Dentsply Sirona Inc	2	$147
Zimvie Inc.	2	$51
SS White Burs LLC	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NOBELACTIVE$438
NOBELPARALLEL$103

How this compares

$2,690 in reported general payments places this provider in the 80th percentile of 605 oral and maxillofacial surgery providers in New York.

See all oral and maxillofacial surgery providers in New York →

Medicare billing

Part B allowed, 2024

$15,068

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Chlorhexidine Gluconate	100	$376
Amoxicillin	125	$337
Azithromycin	33	$128
Clindamycin Hcl	11	$63

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Westbury

Daniel BuchbinderNew York$422K
Jay NeugartenLake Success$393K
Bart SilvermanNew City$310K
Vasiliki KarlisNew York$201K
Yan TrokelNew York$86K
Evan ChafitzYonkers$70K
Vincent AquinoBuffalo$63K
Shahin GhobadiMamaroneck$62K
Michael MarkiewiczBuffalo$61K
Jairo BastidasBronx$56K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →